Trial Profile
Clinical Trials Insight: 700019737
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 13 Dec 2006
Price :
$35
*
At a glance
- Drugs XBD 173 (Primary)
- Indications Panic disorder
- Focus Therapeutic Use
- Sponsors Sumitomo Pharma
- 13 Dec 2006 New trial record.